About James Iversen
Form D filings for Sen-Jam Pharmaceutical from 2020 to 2024 list James Iversen as executive officer and director.
James Iversen first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name James Iversen in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people James Iversen works with at each company, as listed on that company's latest Form D.
Sen-Jam Pharmaceutical Inc. · Form D/A, Jul 25, 2024
JI
Jacqueline Iversen
Executive officer